Compounds having estrogen receptor alpha degradation activity and uses thereof
US9944632B2 · kind B2 · utility
2Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2017 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Jul 11, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of estrogen-related diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.